[1] Headache Classification Committee of the International Headache Society(IHS). The international classification of headache disorders,3rd edition[J]. Cephalalgia,2018,38(1):1-211.
[2] NEUWELT E A,BAUER B,FAHLKE C,et al. Engaging neuroscience to advance translational research in brain barrier biology[J]. Nat Rev Neurosci,2011,12(3):169-182.
[3] DANEMAN R. The blood-brain barrier in health and disease[J]. Ann Neurol,2012,72(5):648-672.
[4] SALVARANI C,BROWN R D JR,CALAMIA K T,et al. Primary central nervous system vasculitis:analysis of 101 patients[J]. Ann Neurol,2007,62(5):442-451.
[5] JOHN S,HAJJ-ALI R A. Headache in autoimmune diseases[J]. Headache,2014,54(3):572-582.
[6] GONZALEZ-GAY M A,VAZQUEZ-RODRIGUEZ T R,LOPEZ-DIAZ M J,et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica[J]. Arthritis Rheum,2009,61(10):1454-1461.
[7] GONZALEZ-GAY M A,BARROS S,LOPEZDIAZ M J,et al. Giant cell arteritis:disease patterns of clinical presentation in a series of 240 patients[J]. Medicine(Baltimore),2005,84(5):269-276.
[8] AREND W P,MICHEL B A,BLOCH D A,et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum,1990,33(8):1129-1134.
[9] KIM H J,SUH D C,KIM J K,et al. Correlation of neurological manifestations of Takayasu's arteritis with cerebral angiographic findings[J]. Clin Imaging,2005,29(2):79-85.
[10] PAGNOUX C,SEROR R,HENEGAR C,et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa:a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French vasculitis study group database[J]. Arthritis Rheum,2010,62(2):616-626.
[11] WALZ LEBLANC B A,KEYSTONE E C,FELTIS J T,et al. Polyarteritis nodosa clinically masquerading as temporal arteritis with lymphadenopathy[J]. J Rheumatol,1994,21(5):949-952.
[12] BERT R J,ANTONACCI V P,BERMAN L,et al. Polyarteritis nodosa presenting as temporal arteritis in a 9-year-old child[J]. AJNR Am J Neuroradiol,1999,20(1):167-171.
[13] YUN S H,YANG N R,PARK S A. Associated symptoms of Kawasaki disease[J]. Korean Circ J,2011,41(7):394-398.
[14] G U I L L E V I N L,DURAND-GASSELIN B,CEVALLOS R,et al. Microscopic polyangiitis:clinical and laboratory findings in eighty-five patients[J]. Arthritis Rheum,1999,42(3):421-430.
[15] TAUSEEF A,ASGHAR M S,AMIR M,et al. Microscopic polyangiitis:an incidental finding in a patient with stroke[J]. J Community Hosp Intern Med Perspect,2020,10(1):50-54.
[16] REINHOLD-KELLER E,BEUGE N,LATZA U,et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis:long-term outcome in 155 patients[J]. Arthritis Rheum,2000,43(5):1021-1032.
[17] N I SH I NO H,RUBINO F A,DE R E M E E R A,et al. Neurological involvement in Wegener's granulomatosis:an analysis of 324 consecutive patients at the Mayo Clinic[J]. Ann Neurol,1993,33(1):4-9.
[18] VĂCĂR AŞ V,RADU R M,CUCU E,et al. Multiple strokes and cerebral microangiopathy in a patient with Churg-Strauss syndrome[J]. Med Pharm Rep,2021,94(1):121-124.
[19] AL-ARAJI A,KIDD D P. Neuro-Behçet's disease:epidemiology,clinical characteristics,and management[J]. Lancet Neurol,2009,8(2):192-204.
[20] B O R H A N I H A G H I G H I A,AFLAKI E,KETABCHI L. The prevalence and characteristics of different types of headache in patients with Behçet's disease,a case-control study[J]. Headache,2008,48(3):424-429.
[21] ANTONIOS N,SILLIMAN S. Cogan syndrome:an analysis of reported neurological manifestations[J]. Neurologist,2012,18(2):55-63.
[22] PAGNINI I,ZANNIN M E,VITTADELLO F,et al. Clinical features and outcome of Cogan syndrome[J/OL]. J Pediatr,2012,160(2):303-307,e1[2021-12-02]. https://doi.org/10.1016/j.jpeds.2011.07.051.
[23] AKROUT R,BENDJEMAA S,FOURATI H,et al. Cerebral rheumatoid vasculitis:a case report[J/OL]. J Med Case Rep,2012,6:302[2021-12-02]. https://doi.org/10.1186/1752-1947-6-302.
[24] BURNS T M. Neurosarcoidosis[J]. Arch Neurol,2003,60(8):1166-1168.